12/20
01:30 am
cmnd
Clearmind Medicine (NASDAQ:CMND) was upgraded by analysts at
Wall Street
Low
Report
Clearmind Medicine (NASDAQ:CMND) was upgraded by analysts at
Wall Street
12/16
09:23 am
cmnd
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100 [Yahoo! Finance]
Medium
Report
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100 [Yahoo! Finance]
12/16
08:45 am
cmnd
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100
Medium
Report
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100
12/12
08:37 am
cmnd
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment [Yahoo! Finance]
Medium
Report
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment [Yahoo! Finance]
12/12
08:32 am
cmnd
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
Medium
Report
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
12/12
07:39 am
cmnd
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement [Yahoo! Finance]
Medium
Report
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement [Yahoo! Finance]
12/12
07:38 am
cmnd
Clearmind Medicine regains compliance with Nasdaq [Seeking Alpha]
Medium
Report
Clearmind Medicine regains compliance with Nasdaq [Seeking Alpha]
12/12
06:32 am
cmnd
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
Medium
Report
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
12/10
04:46 pm
cmnd
Clearmind Medicine Announces 1-for-40 Reverse Share Split [Yahoo! Finance]
High
Report
Clearmind Medicine Announces 1-for-40 Reverse Share Split [Yahoo! Finance]
12/10
04:28 pm
cmnd
Clearmind Medicine to enact 1-for-40 reverse share split; shares down [Seeking Alpha]
High
Report
Clearmind Medicine to enact 1-for-40 reverse share split; shares down [Seeking Alpha]
12/10
04:15 pm
cmnd
Clearmind Medicine Announces 1-for-40 Reverse Share Split
High
Report
Clearmind Medicine Announces 1-for-40 Reverse Share Split
12/5
06:13 pm
cmnd
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification [Yahoo! Finance]
Low
Report
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification [Yahoo! Finance]
12/5
05:00 pm
cmnd
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
Low
Report
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
12/2
07:57 am
cmnd
Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder
Low
Report
Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder
12/1
09:13 am
cmnd
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial [Yahoo! Finance]
Medium
Report
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial [Yahoo! Finance]
12/1
08:56 am
cmnd
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial
Medium
Report
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial
11/25
07:17 am
cmnd
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial
High
Report
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial
11/24
08:51 am
cmnd
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review
Medium
Report
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review
11/20
06:01 am
cmnd
Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site
Low
Report
Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site
11/18
09:24 am
cmnd
Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder [Yahoo! Finance]
High
Report
Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder [Yahoo! Finance]
11/18
08:56 am
cmnd
Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
High
Report
Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
11/17
08:05 am
cmnd
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression [Yahoo! Finance]
Medium
Report
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression [Yahoo! Finance]
11/17
07:55 am
cmnd
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
Medium
Report
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
11/13
08:54 am
cmnd
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
High
Report
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
11/12
06:25 am
cmnd
Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment
High
Report
Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment